文献速递临床试验与 GCP基础与转化研究

术中右美托咪定输注对成人心脏瓣膜术后谵妄影响的随机双盲安慰剂对照试验方案

Effect of intraoperative dexmedetomidine infusion on delirium in adult patients following cardiac valve surgery: a protocol of a randomized, double-blinded, and placebo-controlled study.
PubMed 文献 · Trials · 2020-07-14

本研究为单中心随机双盲安慰剂对照试验,计划纳入652例成人心脏瓣膜手术患者,比较术中右美托咪定输注与安慰剂对术后7天内谵妄发生率的影响。右美托咪定组在中心静脉置管后10分钟给予0.6 μg/kg负荷剂量,随后以0.4 μg/kg/h持续输注至手术结束;主要结局为术后7天内谵妄发生率。

要点

  • 术中右美托咪定给药方案:置管后10分钟0.6 μg/kg负荷,继以0.4 μg/kg/h至术毕。
  • 主要结局为术后7天内谵妄发生率,次要结局包括机械通气时间、ICU及住院时长等。
  • 该方案已获伦理批准并注册,结果将为心脏瓣膜术后谵妄预防提供证据。

核心结论

  • 该试验旨在明确术中右美托咪定输注能否降低成人心脏瓣膜手术后谵妄发生率。

研究设计与样本

  • 单中心、随机、双盲、安慰剂对照试验,计划纳入652例成人心脏瓣膜手术患者,随机分为右美托咪定组和安慰剂组。

关键数值与推荐

  • 右美托咪定组于中心静脉置管后10分钟输注0.6 μg/kg,随后以0.4 μg/kg/h持续输注至手术结束;安慰剂组以相同速率给予生理盐水。
  • 主要结局为术后7天内谵妄发生率;次要结局包括术后机械通气时间、ICU及住院时长、低血压、急性肾损伤、突发心律失常及30天和90天全因死亡率。

临床怎么用

  • 若结果阳性,术中右美托咪定输注可作为降低心脏瓣膜术后谵妄的干预措施;若阴性,则不支持该用法。

局限性

  • 本文为试验方案,尚未报告实际结果数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Delirium is an acute status of brain dysfunction that commonly occurs in patients who have undergone cardiac surgery, and increases morbidity and mortality. It is associated with risk factors, such as older age, use of narcotics, cardiopulmonary bypass, and hypothermia. Dexmedetomidine infusion might exert a neuroprotective effect. However, the effect of perioperative administration of dexmedetomidine on the incidence of postoperative delirium (POD) in patients undergoing cardiac or non-cardiac surgery is yet controversial. The present study aimed to reveal the effect of intraoperative dexmedetomidine administration on the incidence of delirium in adult patients following cardiac surgery. METHODS: This single-center, randomized, double-blinded, and placebo-controlled trial consisted of 652 patients randomly divided into two groups: dexmedetomidine and placebo. 0.6 μg/kg dexmedetomidine will be infused 10 min after central vein catheterization, followed by a continuous infusion at a speed of 0.4 μg/kg/h until the end of surgery in the dexmedetomidine group, while normal saline will be administered at the same rate in the placebo group. The primary outcome is the incidence of POD during the first 7 days post-surgery. The secondary outcomes include duration of mechanical ventilation after surgery, duration of stay in the intensive care unit and the hospital after surgery, incidence of hypotension during or after dexmedetomidine infusion, acute kidney injury and sudden arrhythmia during the hospital stay postoperatively, and all-cause mortality in 30 and 90 days after surgery, respectively. DISCUSSION: This study was approved by the Ethics Committee of the Chinese Academy of Medical Sciences Fuwai Hospital on 6 March 2019 (2019-1180). The results will be disseminated at academic conferences and submitted to peer-reviewed publications. Either positive or negative results will provide guidance for clinical practice. TRIAL REGISTRATION: The Chinese Clinical Trial Registry ( http://www.chictr.org.cn ) ChiCTR1900022583. Registered on 17 April 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Wang HB, Zhang L, Zhang Z, et al. Effect of intraoperative dexmedetomidine infusion on delirium in adult patients following cardiac valve surgery: a protocol of a randomized, double-blinded, and placebo-controlled study. Trials. 2020. PMID: 32665034. doi:10.1186/s13063-020-04574-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。